Our research shows the transformative effect that alemtuzumab can have for people with MS.
Patients who continue to show disease activity while on their initial therapy are especially difficult to treat.
Now, we have shown that alemtuzumab works where first-line drugs have already failed.
It not only reduces the chances of disability associated with MS but may even result in long-term clinical improvements.
More top news
Prince Harry's girlfriend Meghan Markle was spotted in the stands at the opening ceremony of the Invictus Games in Toronto.
Soul legend Otis Redding led the tributes to the singer who released his debut album just six years ago at the age of 62.
The shadow home secretary will tell the Labour conference the Tories have pandered to anti-immigrant sentiment and set "bogus" targets.